,,ii  #aah? ,,congress  #a/ ,session    
,s4 #biai  ,,9 ,,! ,,s5ate ,,( ,,!      
,,unit$ ,,/ates  ,septemb] #bf          
7legislative day1 ,septemb] #bb71       
#bjbc,ms4 ,hassan 7= h]self & ,mr4      
,cornyn7 introduc$ ! foll[+ bill2 :i* 0 
read twice & ref]r$ to ! ,committee on  
,heal?1 ,education1 ,labor1 & ,p5sions  
,a ,,bill  ,to require rese>* ) respect 
to f5tanyl & xylaz9e te/ /rips1 to      
au?orize ! use ( grant funds = su* te/  
/rips1 & = o!r purposes4  #a4 ,%ort     
title ,?is ,act may be cit$ z ! ,advanc+
 ,lifesav+ ,ef=ts ) ,rapid ,te/ /rips = 
,communities ,act or ! ,,al]t           
,communities ,act4  #b4 ,grant program f
 ,/ate & ,tribal response to opioid use 
disord]s ,section #ajjc7;b77#d77;,a7 ( !
 #ba/ ,c5tury ,cures ,act 7#db ,u4,s4,c4
 #bij;ee-#c note7 is am5d$ by ins]t+ or 
f5tanyl or xylaz9e te/ /rips 7z def9$ 9 
section #f ( ! ,advanc+ ,lifesav+ ,ef=ts
 ) ,rapid ,te/ /rips = ,communities     
,act7 be=e ! p]iod at ! end4  #c4 ,fir/ 
respond] tra9+ ,section #edf7;c7 ( !    

,public ,heal? ,s]vice ,act 7#db        
,u4,s4,c4 #bij;ee-#a7;c77 is am5d$--    
7#a7 9 p>agraph 7#c71 by /rik+ 2 & &    
ins]t+ a semicolon2  7#b7 9 p>agraph    
7#d71 by /rik+ ! p]iod & ins]t+ 2 &2 &  
7#c7 by add+ at ! end ! foll[+3  7#e7   
tra9 & provide res\rces = fir/ respond]s
 & memb]s ( o!r relevant community      
sectors on c>ry+ & facilitat+ access to 
f5tanyl or xylaz9e te/ /rips 7z def9$ 9 
section #f ( ! ,advanc+ ,lifesav+ ,ef=ts
 ) ,rapid ,te/ /rips = ,communities     
,act74  4  #d4 ,rese>* & m>ket+         
frameworks = te/ /rip te*nology ,!      
,secret>y ( ,heal? & ,human ,s]vices1 9 
consultation ) ! ,director ( ! ,national
 ,in/itutes ( ,heal?1 ! ,director ( !   
,(fice ( ,national ,drug ,control       
,policy1 ! ,commission] ( ,food &       
,drugs1 & ! ,adm9i/rator ( ! ,drug      
,en=cem5t ,adm9i/ration1 %all develop & 
make publicly available rese>* & m>ket+ 
frameworks = develop+1 improv+1 &       
evaluat+ te/ /rip te*nology = detect+   
f5tanyl & o!r dang]\s sub/ances4 ,su*   

frameworks %all-- 7#a7 include /&>ds &  
guidance = manufactur]s seek+ to develop
 & te/ new te/ /rip te*nology2  7#b7    
emphasize br++ new te/ /rip te*nology   
int5d$ = te/+ human specim5s 9 cl9ical  
sett+s to support on-site cl9ical       
decision-mak+2 &  7#c7 include guidance 
on available au?orization pa?ways = te/ 
/rips describ$ 9 p>agraphs 7#a7 & 7#b74 
#e4 ,/udy on f5tanyl te/ /rip           
int]v5tions ,! ,secret>y ( ,heal? &     
,human ,s]vices %all-- 7#a7 conduct a   
/udy on ! impact ( ! availability1      
accessibility1 & usage ( drug *eck+     
supplies1 includ+ te/ /rips1 on frequ5cy
 ( ov]dose1 ov]dose dea?s1 & engagem5t 9
 sub/ance use disord] treatm5t2 &  7#b7 
n lat] ?an #b ye>s aft] ! date (        
enactm5t ( ?is ,act1 submit to ,congress
 a report on ! /udy conduct$ "u p>agraph
 7#a74  #f4 ,def9ition ,9 ?is ,act1 !   
t]m te/ /rip means a rapid response1    
s+le use diagno/ic t c be us$ to detect 
! adult]ation ( a drug )1 or ! pres5ce 9
 a human specim5 (1 any sub/ance t may  

lead to increas$ morbidity or mortality1
 su* z f5tanyl1 xylaz9e1 or ano!r       
syn!tic opioid or em]g+ sub/ance4